Unlocking the value potential of the human genome for self-sovereign patient data management and advanced precision healthcareJuly 23, 2018 — Phoenix, AZ and Basel, Switzerland: Genebook (https://genebook.io), a global DNA-based marketplace that allows individuals to safely own their genetic code, has agreed to join the Sweetbridge Alliance Network as an industry partner project in the Life Sciences ecosystem.Under the agreement, the two companies agree to share a common blockchain-based token incentive framework and exchange capabilities. This will allow joint citizens of the Genebook marketplace and Sweetbridge economy to realize mutual benefits for improving genetic-related diagnostic and research services, liquidity and monetization of private genome data, and discounted or free access to valuable health and wellness services.“We look forward to having a healthcare economic system that becomes more personalized for your specific needs. Where every citizen can own his or her own genetic information, and use that valuable data to create liquidity and get value-based services provided back to them to improve their overall quality of life,” said Daniel Gutierrez, CEO and co-founder, Genebook.“Optimizing the healthcare and pharmaceutical supply chain of the future will require unlocking the massive value hidden within human genetics, while responsibly driving innovation with total personal privacy and economic transparency,” said Mac McGary, President of Sweetbridge Alliance Network. “We are eager to explore this future state of life sciences that can benefit all by working with Genebook.”The Genebook marketplace allows anyone to own their genetic data, and control exactly how this self-sovereign genome data can be used with full anonymity and identity safeguards, for discretely permissioned use by research institutions, pharma companies, insurers and governmental health organizations in developing new medicines, treatments and policies.Genebook creates a patient-centric solution for securely storing and leveraging genetic data, allowing value-based offers to be presented to data owners. [Source: Genebook]“Through our shared research into precision medicine at leading pharma companies and medical institutions, we realized that genetics are the future of healthcare innovation,” said Bhupinder Bhullar, co-founder and Chief Scientist, Genebook. “Human genomes, and the vast phenomic data that can accompany them, represent the best individualized ‘gold’ to re-bridge the gap between patients and the delivery of new advanced cures and preventative treatments.”The Genebook project is currently building a blockchain network allowing secure and anonymized genetic information storage and permissioned search capabilities, an incentive structure for offering value-added services and token payments from industry members, as well as a hardware solution for off-network secure personal “cold-storage” of any citizen’s complete genetic data and indicators.The Sweetbridge Alliance team recently posted an in-depth interview of the Genebook co-founders on the SweetTalk podcast and blog, available here: https://blog.sweetbridge.com/sweetbridge-alliance-podcast-video-genebook-flattening-the-genetic-economy-b6cde8c85a8fGenebook co-founders Gutierrez and Bhullar will be presenting their solution and hosting a discussion panel on genetics and life sciences September 14, 2018 at the event “Basel Life Forum” [https://baselife.org] in their headquarters city of Basel, Switzerland.About GenebookGenebook is a global DNA-based marketplace that allows individuals to safely own their genetic code. Using blockchain and smart contracts, Genebook empowers its users to anonymously share their DNA data, and capture all the profit from the value it creates. Visit https://genebook.io to learn more.About SweetbridgeSweetbridge is a new economy built for commerce that enhances the world’s current economies. Sweetbridge and its alliance partners offer a unique set of blockchain protocols, applications and crypto-economics to create an economy of opportunity for all participants. The goal of Sweetbridge is to transform brittle, industrial-era commerce through decentralized industry ecosystems that create a faster, fairer value exchange, unleash working capital, better utilize resources, and optimize talent for the benefit of all participants. For more information, follow Sweetbridge on Twitter at @sweetbridgeinc or visit https://sweetbridge.com.Genebook Joins the Sweetbridge Alliance Network Life Sciences Ecosystem was originally published in Sweetbridge on Medium, where people are continuing the conversation by highlighting and responding to this story.